tiprankstipranks
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market
NVCT
Nuvectis Pharma
RESEARCH TOOLSreports
Want to see NVCT full AI Analyst Report?

Nuvectis Pharma (NVCT) Financial Statements

117 Followers

Nuvectis Pharma Financial Overview

Nuvectis Pharma's market cap is currently $235.51M. The company's EPS TTM is $-1.32; its P/E ratio is -5.63; Nuvectis Pharma is scheduled to report earnings on May 5, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -27.57M$ -19.85M$ -22.90M$ -19.23M$ -12.89M
EBITDA$ -27.57M$ -19.00M$ -22.90M$ -19.23M$ -12.89M
Net Income$ -26.44M$ -19.00M$ -22.26M$ -19.09M$ -12.89M
Balance Sheet
Cash & Short-Term Investments$ 31.63M$ 18.53M$ 19.13M$ 19.99M$ 5.74M
Total Assets$ 31.71M$ 18.61M$ 19.18M$ 20.41M$ 6.66M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -31.63M$ -18.53M$ -19.13M$ -19.99M$ -5.74M
Total Liabilities$ 13.30M$ 8.89M$ 6.98M$ 6.19M$ 17.66M
Stockholders' Equity$ 18.41M$ 9.71M$ 12.20M$ 14.22M$ -11.01M
Cash Flow
Free Cash Flow$ -16.01M$ -12.25M$ -15.95M$ -13.56M$ -9.50M
Operating Cash Flow$ -16.01M$ -12.25M$ -15.95M$ -13.56M$ -9.50M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 29.11M$ 11.65M$ 15.09M$ 27.81M$ 15.25M
Currency in USD

Nuvectis Pharma Earnings and Revenue History

Income Statement >

Nuvectis Pharma Debt to Assets

Balance Sheet >

Nuvectis Pharma Cash Flow

Cash Flow >

Nuvectis Pharma Forecast EPS vs Actual EPS

Earnings >